Saama Blog

Big Data Insights on Saama solutions and services

Clinical Trial Excellence for Tomorrow and Beyond Blog Series Concluding Post

By Ken Massey | November 6, 2018

In September, Saama initiated a novel blog series, Clinical Trial Excellence for Tomorrow and Beyond, which proudly showcased the experience and expertise of the six newest members of Saama’s Clinical Board of Advisors. These stellar professionals offered insightful commentary and informed predictions about the current and future role AI-enabled data analytics will play in the life science industry’s ongoing clinical development efforts.

Read More

Saama to the Rescue: Trial Manager

By Luke Stewart | October 31, 2018

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Cost Considerations: Data Analytics for Biotech Clinical Trials

By Jay Kaminski | October 29, 2018

This week concludes Saama’s Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which has been authored by one of our six new Clinical Board of Advisor members. In this final post, Jay Kaminski  , Chief Operating Officer at Celularity and former Senior Vice President of Global Clinical Research & Development Operations at Celgene Corporation, explores the challenges…

Read More

Saama to the Rescue: Central Monitor

By Dr. Anand Dubey | October 25, 2018

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Saama to the Rescue: Data Manager

By Luke Stewart | October 18, 2018

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Cost Considerations: Critical for Clinical Trials

By John Fox | October 15, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, John Fox, Vice President of Global Payroll at Johnson & Johnson and Vice President of Information Technology at Pharmaceuticals Group, addresses the financial considerations that…

Read More

Bring a drug to market 1 year early, save $85M along the way

By Amit Gulwadi | October 11, 2018

This is Part #1 of a blog series describing how disruptive innovation technologies such as Saama’s Life Science Analytics Cloud is enabling the Pharma industry to bend its clinical development cost curve sharply downwards while bringing cures to patients sooner. Co-authored by Nekzad Shroff,  Vice President for Business Consulting and Enablement and Amit Gulwadi,  Senior Vice…

Read More

Saama to the Rescue: The Clinical Trial Manager’s Trials

By Dr. Anand Dubey | October 10, 2018

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Streamlining Clinical Trials for the Future

By Scot Harper | October 8, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Scot Harper, Ph.D., President of SLH Group, a life sciences consulting company and previously CEO of Novartis Clinical Operations, address some steps life science industry clinical…

Read More

Open Innovation and Co-Innovation

By Sagar Anisingaraju | October 2, 2018

Saama’s Chief Strategy Officer Sagar Anisingaraju, recently attended the World Forum Disrupt Open Innovation Strategy & Conference in San Francisco, September 18-19, 2018, and participated in a panel on Open Innovation and Co-Innovation, hosted by Pamela Rice, FinTech Executive, Advisor and Innovator. Below are excerpts from Sagar’s discussion points on that topic. Pamela Rice: We are…

Read More

Clinical Development: “A Futuristic View”

By Stephen Cunningham | October 1, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Stephen Cunningham, M.D., President, SRC Pharma Consult; former Chief Scientific Officer and Head of U.S. Clinical Development, Medical Affairs and Evidence-Based Medicine, Novartis, discusses the types…

Read More

Saama to the Rescue: The Portfolio Lead’s Dilemma

By Luke Stewart | September 27, 2018

In any clinical study, trial leadership at every level have an abundance of details to manage, people to supervise, deadlines to meet, and budgets administer, among other things. What trial leadership does not have is an abundance of time to solve the inevitable challenges that arise in relation to these various moving parts. Saama can…

Read More

The Long Road to Transformation

By Opinder Bawa | September 24, 2018

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Opinder Bawa, Vice President and Chief Information Officer at the University of San Francisco and former UCSF Chief Technology Officer, discusses what technology developments and…

Read More

Partnerships for Optimizing Clinical Trial Success

By Jonathan Zung | September 17, 2018

Saama is proud to kick-off the first installment of our Clinical Trial Excellence for Tomorrow and Beyond blog series, each of which will be authored by one of Saama’s six new Clinical Board of Advisors members. This week, Jonathan Zung, Ph.D. President of Clintrax and former Group President of Clinical Development & Commercialization Services at Covance Drug Development, offers…

Read More

Clinical Trial Excellence for Tomorrow and Beyond: Part 1

By Ken Massey | September 10, 2018

As part of our continually expanding footprint as a data analytics leader, Saama is pleased to announce the addition of six new life science industry luminaries to our Clinical Board of Advisors: Opinder Bawa, Vice President and Chief Information Officer, University of San Francisco; former Chief Technology Officer, UCSF. Stephen Cunningham, M.D., President, SRC Pharma…

Read More

RSS adobe_pdf2

Archives